Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 827-835

  Bürgler, Simone ^a,b,c   Gimeno, Aleix ^a,b   Parente Ribes, Anna ^a   Wang, Dong ^a   Os, Audun ^a   Devereux, Stephen ^d   Jebsen, Peter ^b   Bogen, Bjarne ^a,b   Tjønnfjord, Geir E ^a   Munthe, Ludvig A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; GAMMA INTERFERON; JANUS KINASE 1; JANUS KINASE 2; STAT PROTEIN; TRANSCRIPTION FACTOR T BET; CD38 PROTEIN, HUMAN; IFNG PROTEIN, HUMAN; MEMBRANE PROTEIN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CD38 GENE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COCARCINOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE MIGRATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; TH1 CELL; ADULT; AGED; ANIMAL; CANCER TRANSPLANTATION; CELLULAR IMMUNITY; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALE; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; XENOGRAFT;

ADULT; AGED; ANIMALS; ANTIGENS, CD38; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HETEROGRAFTS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; T-BOX DOMAIN PROTEINS; TH1 CELLS;

EID: 84920434129     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401350     Document Type: Article

References (48)

1. Damle, R. N., T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S. L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, et al. 1999. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840-1847.
2. Damle, R. N., S. Temburni, C. Calissano, S. Yancopoulos, T. Banapour, C. Sison, S. L. Allen, K. R. Rai, and N. Chiorazzi. 2007. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 110: 3352-3359.
3. Calissano, C., R. N. Damle, G. Hayes, E. J. Murphy, M. K. Hellerstein, C. Moreno, C. Sison, M. S. Kaufman, J. E. Kolitz, S. L. Allen, et al. 2009. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia. Blood 114: 4832-4842.
4. Tretter, T., M. Schuler, F. Schneller, U. Brass, M. Esswein, M. J. Aman, C. Huber, and C. Peschel. 1998. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro. Cell. Immunol. 189: 41-50.
5. Patten, P., S. Devereux, A. Buggins, M. Bonyhadi, M. Frohlich, and R. J. Berenson. 2005. Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia. J. Immunol. 174: 6562- 6563, author reply 6563.
6. Patten, P. E., A. G. Buggins, J. Richards, A. Wotherspoon, J. Salisbury, G. J. Mufti, T. J. Hamblin, and S. Devereux. 2008. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111: 5173-5181.
7. Vaisitti, T., S. Aydin, D. Rossi, F. Cottino, L. Bergui, G. D'Arena, L. Bonello, A. L. Horenstein, P. Brennan, C. Pepper, et al. 2010. CD38 increases CXCL12- mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia 24: 958-969.
8. Malavasi, F., S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin. 2008. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88: 841-886.
9. Aydin, S., D. Rossi, L. Bergui, G. D'Arena, E. Ferrero, L. Bonello, P. Omedé, D. Novero, F. Morabito, A. Carbone, et al. 2008. CD38 gene polymorphism and chronic lymphocytic leukemia: A role in transformation to Richter syndrome? Blood 111: 5646-5653.
10. Ghia, P., G. Strola, L. Granziero, M. Geuna, G. Guida, F. Sallusto, N. Ruffing, L. Montagna, P. Piccoli, M. Chilosi, and F. Caligaris-Cappio. 2002. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur. J. Immunol. 32: 1403-1413.
11. Os, A., S. Bürgler, A. P. Ribes, A. Funderud, D. Wang, K. M. Thompson, G. E. Tjønnfjord, B. Bogen, and L. A. Munthe. 2013. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Cell Reports 4: 566-577.
12. Buschle, M., D. Campana, S. R. Carding, C. Richard, A. V. Hoffbrand, and M. K. Brenner. 1993. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177: 213-218.
13. Wilkinson, P. C., and L. N. Islam. 1989. Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes. Immunology 67: 237-243.
14. Cordingley, F. T., A. Bianchi, A. V. Hoffbrand, J. E. Reittie, H. E. Heslop, A. Vyakarnam, M. Turner, A. Meager, and M. K. Brenner. 1988. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1: 969-971.
15. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
16. Dorfman, D. M., E. S. Hwang, A. Shahsafaei, and L. H. Glimcher. 2004. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Am. J. Clin. Pathol. 122: 292-297.
17. Serre, K., A. F. Cunningham, R. E. Coughlan, A. C. Lino, A. Rot, E. Hub, K. Moser, R. Manz, A. Ferraro, R. Bird, et al. 2012. CD8 T cells induce T-bet- dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines. Blood 120: 4552-4559.
18. Harris, D. P., S. Goodrich, A. J. Gerth, S. L. Peng, and F. E. Lund. 2005. Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J. Immunol. 174: 6781-6790.
19. Peng, S. L., S. J. Szabo, and L. H. Glimcher. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99: 5545-5550.
20. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475- 482.
21. Nelson, J. D., O. Denisenko, and K. Bomsztyk. 2006. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1: 179-185.
22. Burger, J. A., M. P. Quiroga, E. Hartmann, A. Bürkle, W. G. Wierda, M. J. Keating, and A. Rosenwald. 2009. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 113: 3050-3058.
23. Pittner, B. T., T. D. Shanafelt, N. E. Kay, and D. F. Jelinek. 2005. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 19: 2264-2272.
24. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142.
25. Singer, C. A. 2011. T-bet is induced by interferon-γ to mediate chemokine secretion and migration in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L633-L641.
26. Partidá-Sánchez, S., L. Rivero-Nava, G. Shi, and F. E. Lund. 2007. CD38: An ecto-enzyme at the crossroads of innate and adaptive immune responses. Adv. Exp. Med. Biol. 590: 171-183.
27. Lagneaux, L., A. Delforge, D. Bron, C. De Bruyn, and P. Stryckmans. 1998. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 91: 2387- 2396.
28. Buggins, A. G., C. Pepper, P. E. Patten, S. Hewamana, S. Gohil, J. Moorhead, N. Folarin, D. Yallop, N. S. Thomas, G. J. Mufti, et al. 2010. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Cancer Res. 70: 7523-7533.
29. Dührsen, U., W. Augener, T. Zwingers, and G. Brittinger. 1987. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: Analysis of 637 cases and comparison with myeloproliferative diseases. Br. J. Haematol. 67: 235-239.
30. Rozovski, U., M. J. Keating, and Z. Estrov. 2013. Targeting inflammatory pathways in chronic lymphocytic leukemia. Crit. Rev. Oncol. Hematol. 88: 655-666.
31. Lund, F. E., and T. D. Randall. 2010. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat. Rev. Immunol. 10: 236-247.
32. Beima, K. M., M. M. Miazgowicz, M. D. Lewis, P. S. Yan, T. H. Huang, and A. S.Weinmann. 2006. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J. Biol. Chem. 281: 11992-12000.
33. Sivina, M., E. Hartmann, T. J. Kipps, L. Rassenti, D. Krupnik, S. Lerner, R. LaPushin, L. Xiao, X. Huang, L. Werner, et al. 2011. CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood 117: 1662-1669.
34. Ysebaert, L., and J. J. Fournié. 2011. Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia. Leuk. Lymphoma 52: 1404-1406.
35. Hoogendoorn, M., J. O. Wolbers, W. M. Smit, M. R. Schaafsma, R. M. Barge, R. Willemze, and J. H. Falkenburg. 2004. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia 18: 1278-1287.
36. Aguilar-Santelises, M., R. Magnusson, S. B. Svenson, A. Loftenius, B. Andersson, H. Mellstedt, and M. Jondal. 1991. Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. Clin. Exp. Immunol. 84: 422-428.
37. Mainou-Fowler, T., and A. G. Prentice. 1996. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma 21: 369- 377.
38. Hu, X., P. K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T. T. Lu, J. R. Woodgett, and L. B. Ivashkiv. 2006. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563-574.
39. Arpin, C., J. Déchanet, C. Van Kooten, P. Merville, G. Grouard, F. Brière, J. Banchereau, and Y. J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268: 720-722.
40. Fluckiger, A. C., I. Durand, and J. Banchereau. 1994. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 179: 91-99.
41. Bauvois, B., L. Durant, J. Laboureau, E. Barthélémy, D. Rouillard, G. Boulla, and P. Deterre. 1999. Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II. J. Interferon Cytokine Res. 19: 1059-1066.
42. Galibert, L., N. Burdin, B. de Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau, and F. Rousset. 1996. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183: 77-85.
43. Hibbert, L., S. Pflanz, R. De Waal Malefyt, and R. A. Kastelein. 2003. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 23: 513-522.
44. Landgren, O., M. Albitar, W. Ma, F. Abbasi, R. B. Hayes, P. Ghia, G. E. Marti, and N. E. Caporaso. 2009. B-cell clones as early markers for chronic lymphocytic leukemia. N. Engl. J. Med. 360: 659-667.
45. Aguilar-Santelises, M., A. Loftenius, C. Ljungh, S. B. Svenson, B. Andersson, H. Mellstedt, and M. Jondal. 1992. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis. Leuk. Res. 16: 607-613.
46. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643.
47. Caligaris-Cappio, F. 1996. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87: 2615-2620.
48. Fulcher, D. A., A. B. Lyons, S. L. Korn, M. C. Cook, C. Koleda, C. Parish, B. Fazekas de St Groth, and A. Basten. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183: 2313-2328.